Chirality and pharmacokinetics
Chirality and drugs
Article REF: P3340 V1
Chirality and pharmacokinetics
Chirality and drugs

Author : Serge KIRKIACHARIAN

Publication date: March 10, 2005, Review date: January 1, 2021 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

5. Chirality and pharmacokinetics

As a general rule, whether we're talking about a racemate, a pure enantiomer or a non-chiral drug, knowledge of pharmacokinetic parameters is essential before any drug can be marketed. Pharmacokinetics enable us to determine absorption rates, binding to plasma proteins, distribution to various tissues, metabolism with or without the formation of one or more metabolites, elimination and half-life, all of which help define the drug's mode of use.

Moreover, since amino acids, carbohydrates, complex lipids and macromolecules in living matter such as plasma proteins, enzymes, membrane and nuclear receptors are asymmetric, interactions with chiral molecules can be enantioselective, leading to different pharmacokinetic parameters for each enantiomer. The same applies to the action of enzymes, which may act differently on each enantiomer, leading to the formation of different...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Drugs and pharmaceuticals"

( 123 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us